Rydapt / Ridapt / Mitikayd (midostaurin) 25 mg capsules, 112 capsules — original (Novartis) Targeted cancer therapy. Delivery of medications from Europe and beyond within 4-5 days, storage conditions observed, payment upon receipt. Order by number 380996042415, Viber, WhatsApp.
Indications for Use
Studied for use/treatment of adult patients with high-risk acute myeloid leukemia (AML) with a FLT3 mutation, aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological malignancies (SM-AN), or mast cell leukemia (MCL).
Dosage
50 mg twice daily from days 8 to 21
- Trade Name:Ridapt
- Chemical Name:Midostaurin
- Dosage:25 mg
- Quantity:112
- Form of Issue:Tablets
No reviews yet